Amarin Corp Plc (AMRN)

[CaptBeer]

RCT's in East Asian Populations have shown a "causal association of elevated remnant cholesterol with increased risk of ASCVD."

"In the East Asian context, in the JELIS trial with 18,645 Japanese individuals with hypercholesterolemia, EPA on top of statins showed a 19% relative reduction of major coronary events. From these results as well as the results from the REDUCE-IT trial, EPA not EPA+DHA could be beneficial; however, further investigations are needed to conclude the efficacy of omega-3 fatty acids."